David A. Horak, M.D., F.A.C.P., F.C.C.P.

Clinical Specialties

Medical Intensivist

Areas of Expertise

Pulmonary and Critical Care Medicine

Research Focus

Head & Neck and Thoracic Oncology

Other Languages Spoken

Spanish

“I value your decisions, your partnership, your voice.”

For over 30 years, David Horak, M.D., has been a fixture at City of Hope, and for most of that time he has led our Division of Pulmonary and Critical Care Medicine. In addition to working with lung cancer patients, Dr. Horak diagnoses and treats patients suffering from severe respiratory disease, like emphysema or COPD.

Dr. Horak graduated from Stanford University and received his medical degree from University of California, Los Angeles, going on to complete his internship, residency and fellowship in pulmonary medicine at UCLA/Cedars-Sinai Medical Center.

Dr. Horak also serves as Medical Director of City of Hope's Intensive Care Unit, as well as Medical Director of our Pulmonary Physiology Laboratory. A key player in City of Hope's continuing medical education programs, he moderates regular conferences examining the latest diagnosis and treatment strategies.

Locations

Duarte

1500 East Duarte Road, Duarte, CA, 91010

Get Directions

Phone : 626-256-4673

Education

Degrees

1974 -1978, David Geffen School of Medicine at UCLA, Los Angeles, CA, M.D
1970 -1974, Stanford University, CA, B.S. with Distinction, Biology

Fellowship

1981 -1983, Fellow in Pulmonary Medicine, Cedars-Sinai Medical Center, David Geffen School of Medicine at UCLA, Los Angeles, CA

Residency

1979 -1981, Internal Medicine Residency, Cedars-Sinai Medical Center, David Geffen School of Medicine at UCLA, Los Angeles, CA

Internship

1978 -1979, Straight Medical Internship, Cedars-Sinai Medical Center, David Geffen School of Medicine at UCLA, Los Angeles, CA

Board Certifications

2007, Critical Care Medicine Board Recertification, American Board of Internal Medicine
1997, Critical Care Medicine Board Recertification, American Board of Internal Medicine
1987, Critical Care Medicine Board Certification, American Board of Internal Medicine
1984, Pulmonary Disease Subspecialty Board Certification, American Board of Internal Medicine
1983, Advanced Trauma Life Support Certification
1982-present, American Red Cross Advanced CPR Certification
1981, Radiation Supervisor Certification, State of California
1981, Diplomate American Board of Internal Medicine
1979, Diplomate National Board of Medical Examiners
1979 - present, California Medical License
1979 - present, DEA

An Expert's Voice

Publications

Groeger JS, Glassman J, Nierman DM, Wallace SK, Price K, Horak D, Landsberg D. Probability of mortality of critically ill cancer patients at 72 h of intensive care unit (ICU) management. Supportive Care Cancer 2003;11:686-695.

Bach PB, Schrag D, Nierman DM, Horak D, White P, Young JW, Groeger JS. Identification of poor prognostic features among patients requiring mechanical ventilation after hematopoietic stem cell transplantation. Blood 2001;98:3234-3240.

Groeger JS, White P Jr, Nierman DM, Glassman J, Shi W, Horak D, Price K. Outcome of Cancer Patients Requiring Mechanical Ventilation. Journal of Clinical Oncology 1999;17:991-997.

Groeger JS, Lemeshow S, Price K, Nierman DM, White P Jr, Klar J, Granovsky S, Horak D, Kish SK. Multicenter Outcome Study of Cancer Patients Admitted to the Intensive Care Unit: A Probability of Mortality Model. Journal of Clinical Oncology 1998;16:761-770.

Horak DA, Schmidt GM, Zaia JA, Niland JC, Ahn C, Forman SJ. Pretransplant pulmonary function predicts cytomegalovirus-associated interstitial pneumonia following bone marrow transplantation. Chest 1992;102:1484-1490.

Levy H, Horak DA, Tegtmeier B, Yokota SB, Forman SJ. The value of bronchoalveolar lavage in the diagnosis of invasive pulmonary aspergillosis. Respiratory Medicine 1992;86:243-248

Schmidt GM, Horak DA, Niland JC, Duncan SR, Forman SJ, Zaia JA and the City of Hope-Stanford-Syntex CMV Study Group. A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in allogeneic bone marrow transplant recipients. New England Journal of Medicine 1991;324:1005-1011.

Desai KR, Horak DA, Levy H, Forell BW, Pezner RD, Lipsett JA, Findley DO. Stability of the transnasal catheter in endobronchial brachytherapy as a function of time. Endocurietherapy / Hyperthermia Oncology 1990;6:65-69.

Pezner RD, Horak DA, Sayagh H, Lipsett JA. Spontaneous pneumothorax in patients irradiated for Hodgkin's disease and other malignant lymphomas. International Journal of Radiation Oncology, Biology and Physics 1990;18:193-198.

Schmidt GM, Kovacs A, Zaia JA, Horak DA, Blume KG, Nadamanee AP O'Donnell MR, Snyder DS and Forman SJ. Ganciclovir/Immunoglobulin combination therapy for the treatment of human cytomegalovirus associated interstitial pneumonia in bone marrow allograft recipients. Transplantation 1988;46:905-907.

Levy H, Horak DA, Lewis MI. The value of bronchial washings and bronchoalveolar lavage in the diagnosis of lymphangitic carcinomatosis. Chest 1988;94:1028-1030.

Lewis M, Horak D. Airflow obstruction in sarcoidosis (editorial). Chest 1987; 92:582-584.

Lewis M, Horak D, Yellin A, Rotter A, Belman M, Benfield J. The case of the moving intrathoracic mass. Chest 1985; 88:897-898.

Mohsenifar Z, Horak D, Brown HV, Koerner SK: Sensitive indices of improvement in a pulmonary rehabilitation program. Chest 1983; 83:189-192.

Memberships

Fellow, American College of Chest Physicians
Fellow, American College of Physicians
Member, American Thoracic Society
Member, California Thoracic Society
Member, National Association for Medical Direction of Respiratory Care
Member, Los Angeles Count